m6A–Mediated epitranscriptomic control of mitochondrial dysfunction in neurodegeneration
Mitochondrion · 2026-09 · 90 · 102166
DOI: 10.1016/j.mito.2026.102166 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mitochondrion, 2026-09. Verfasst von Abhishek Jauhari. Beteiligte Einrichtung: Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA. Electronic address:…. Hauptthemen laut MEDLINE: Mitochondria, Neurodegenerative Diseases, Adenosine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pittsburgh Foundation, University of Pittsburgh.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA. Electronic address: abj33@pitt.edu.
Förderung
- Pittsburgh Foundation
- University of Pittsburgh
Zitieren
APA
Jauhari, A. (2026). m6A–Mediated epitranscriptomic control of mitochondrial dysfunction in neurodegeneration. Mitochondrion, 90, 102166. https://doi.org/10.1016/j.mito.2026.102166
Vancouver
Jauhari A. m6A–Mediated epitranscriptomic control of mitochondrial dysfunction in neurodegeneration. Mitochondrion. 2026;90:102166. doi:10.1016/j.mito.2026.102166
BibTeX
@article{Jauhari2026,
author = {Jauhari, Abhishek},
title = {m6A–Mediated epitranscriptomic control of mitochondrial dysfunction in neurodegeneration},
journal = {Mitochondrion},
year = {2026},
volume = {90},
pages = {102166},
doi = {10.1016/j.mito.2026.102166}
}
EUVIMED